News

Notable healthcare headlines for the week: Novo Nordisk, Medtronic, Novavax in focus

Dow hits record highs & S&P 500 healthcare gains. Discover key stock movers, Trump-era pharma tariffs capped, & major healthcare earnings updates.

Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors

Eli Lilly's orforglipron could have a few advantages over a pill from Novo Nordisk, including a lack of dietary restrictions ...

Mumbai News: Novo Nordisk’s Wegovy And Insulin Consignments Stolen From Bhiwandi Hub; Experts Warn Of Risks From Unsafe, Unsupervised Use

Mumbai: In a serious security and public health concern, several consignments of Novo Nordisk’s injectable medicines — ...

Voices: Yes, Mounjaro is set to treble in price – but don’t abandon weight-loss jabs until you read this

COMMENT: The monthly cost of a private prescription exceeding £300 from next month is worrying news for the half a million ...